Goodwin

Jennifer Fay

Deals
2
Latest
Apr 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 2 deals

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Jennifer Fay was named on, most recent first
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Kelonia Therapeutics (target)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis

Deals where Jennifer Fay is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.